newsfilter
← Latest News
GlobeNewswire·

NervGen Pharma to Host Virtual Investor Event

VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSXV:NGEN) (OTCQB:NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today announced